Trump’s Executive Order Aims to Illegally Undermine Federal Independent Agencies, Shield Big Corporations from Accountability
Comments on the FDA’s Draft Guidance Regarding Evaluation of Bulk Drug Substances Nominated for Use in Compounding Under Section 503B of the Federal Food, Drug, and Cosmetic Act May 25, 2018
Petition to the FDA to Not Allow Marketing of Over-The-Counter Benzocaine Products for Teething in Infants July 28, 2014